Breaking News Instant updates and real-time market news.

RVNC

Revance

$11.57

0.09 (0.78%)

04:55
06/20/19
06/20
04:55
06/20/19
04:55

Revance management to meet with Needham

Meetings to be held in Denver/Salt Lake City on June 19 in Midwest on June 20 hosted by Needham.

  • 20

    Jun

  • 10

    Jul

  • 11

    Jul

RVNC Revance
$11.57

0.09 (0.78%)

02/15/19
WELS
02/15/19
INITIATION
Target $17
WELS
Market Perform
Revance initiated with a Market Perform at Wells Fargo
Wells Fargo analyst David Maris initiated Revance (RVNC) with a Market Perform rating and $17 price target. In a research note to investors, Maris says he believes the market is already anticipating a success of Revance's lead program RT002, and as such, see risk to the downside. Additionally, Maris notes that an approval in glabellar lines would only make Revance "partially competitive" to Allergan's (AGN) Botox.
03/01/19
RHCO
03/01/19
NO CHANGE
Target $29
RHCO
Buy
Revance price target lowered to $29 from $58 at SunTrust
SunTrust analyst Ashwani Verma lowered his price target on Revance to $29 after its wider than expected Q4 loss, saying the lower cost alternatives to Botox "changes the market reality" for the company. The analyst believes that there are few catalysts for Revance this year, but sees 2020 as rich with potentially positive news flow with expected regulatory approval for its glabellar lines product and the results of the phase 2 study of its Plantar Fasciitis / Upper Limb Spasticity program. Verma is keeping his Buy rating on Revance.
03/11/19
GUGG
03/11/19
NO CHANGE
Target $190
GUGG
Buy
Allergan has 'trapped value,' but unlocking will take time, says Guggenheim
Guggenheim analyst Seamus Fernandez reiterated his Buy rating on Allergan (AGN) shares after Rapastinel's Phase 3 failure, stating that he believes the stock's current price already assumes major challenges and he thinks a major restructuring or sale of the business would be viable options to unlock that value. While Allergan's Botox and aesthetics business is not without risks, such as Revance's (RVNC) long-acting neurotoxin and Evolus' (ELOS) Jeuveau, his analysis suggests Botox and aesthetics are worth $46B-$49B, Fernandez tells investors. As a result of lower pipeline estimates and his base case sum of the parts-based valuation of $170 per share, Fernandez lowered his price target on Allergan shares to $190 from $219.
06/11/19
LEHM
06/11/19
INITIATION
Target $28
LEHM
Overweight
Revance initiated with an Overweight at Barclays
Barclays analyst Balaji Prasad started Revance Therapeutics with an Overweight rating and $28 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.

TODAY'S FREE FLY STORIES

WAL

Western Alliance

$43.59

0.025 (0.06%)

07:18
08/23/19
08/23
07:18
08/23/19
07:18
Recommendations
Western Alliance analyst commentary  »

Western Alliance added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$276.05

-0.29 (-0.10%)

07:15
08/23/19
08/23
07:15
08/23/19
07:15
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MCD

McDonald's

$219.39

-1.29 (-0.58%)

, QSR

Restaurant Brands

$75.43

0.21 (0.28%)

07:15
08/23/19
08/23
07:15
08/23/19
07:15
Recommendations
McDonald's, Restaurant Brands, Carrols Restaurant analyst commentary  »

McDonald's…

MCD

McDonald's

$219.39

-1.29 (-0.58%)

QSR

Restaurant Brands

$75.43

0.21 (0.28%)

TAST

Carrols Restaurant

$7.07

-0.2 (-2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 05

    Sep

  • 23

    Sep

  • 13

    Nov

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:14
08/23/19
08/23
07:14
08/23/19
07:14
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary at Oppenheimer »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

ARMK

Aramark

$39.93

0.22 (0.55%)

07:10
08/23/19
08/23
07:10
08/23/19
07:10
Initiation
Aramark initiated  »

Aramark initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRGB

Red Robin

$32.96

-0.64 (-1.90%)

07:10
08/23/19
08/23
07:10
08/23/19
07:10
Earnings
Red Robin cuts FY19 adj. EPS view to 95c-$1.50 from $1.14-$1.77 »

Consensus $1.14. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

CDNA

CareDx

$23.56

-0.16 (-0.67%)

07:07
08/23/19
08/23
07:07
08/23/19
07:07
Recommendations
CareDx analyst commentary at H.C. Wainwright »

CareDx draft LCD should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

RRGB

Red Robin

$32.96

-0.64 (-1.90%)

07:07
08/23/19
08/23
07:07
08/23/19
07:07
Earnings
Red Robin reports Q2 adj. EPS $1.03, consensus 31c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

07:05
08/23/19
08/23
07:05
08/23/19
07:05
General news
FX Action: »

FX Action: The dollar has…

VMW

VMware

$148.15

0.11 (0.07%)

07:03
08/23/19
08/23
07:03
08/23/19
07:03
Recommendations
VMware analyst commentary at KeyBanc »

VMware price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 10

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

07:02
08/23/19
08/23
07:02
08/23/19
07:02
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker down 9% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

ZIOP

Ziopharm

$5.61

0.46 (8.93%)

07:01
08/23/19
08/23
07:01
08/23/19
07:01
Hot Stocks
Ziopharm reports inducement grant under Nasdaq listing rule »

Ziopharm Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

CRM

Salesforce

$148.26

0.86 (0.58%)

07:00
08/23/19
08/23
07:00
08/23/19
07:00
Recommendations
Salesforce analyst commentary at Stifel »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

INTU

Intuit

$276.05

-0.29 (-0.10%)

06:57
08/23/19
08/23
06:57
08/23/19
06:57
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

RBNC

Reliant Bancorp

$22.46

-0.16 (-0.71%)

06:56
08/23/19
08/23
06:56
08/23/19
06:56
Initiation
Reliant Bancorp initiated  »

Reliant Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CLH

Clean Harbors

$75.14

-0.25 (-0.33%)

06:53
08/23/19
08/23
06:53
08/23/19
06:53
Initiation
Clean Harbors initiated  »

Clean Harbors resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$107.31

1.63 (1.54%)

06:53
08/23/19
08/23
06:53
08/23/19
06:53
Recommendations
Ross Stores analyst commentary at Wells Fargo »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$1.89

-0.02 (-1.05%)

06:52
08/23/19
08/23
06:52
08/23/19
06:52
Hot Stocks
Hemispherx changes name to AIM ImmunoTech, effective September 3 »

Hemispherx Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKE

The Buckle

$18.61

0.695 (3.88%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Earnings
The Buckle reports Q2 EPS 34c, consensus 30c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

GPS

Gap

$17.75

0.79 (4.66%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Recommendations
Gap analyst commentary at Wells Fargo »

Gap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

LNDC

Landec

$10.99

-0.07 (-0.63%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Initiation
Landec initiated  »

Landec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELL

Tellurian

$9.19

0.9 (10.86%)

06:49
08/23/19
08/23
06:49
08/23/19
06:49
Downgrade
Tellurian rating change  »

Tellurian downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.43

-0.41 (-0.20%)

, ALXN

Alexion

$123.51

8.64 (7.52%)

06:48
08/23/19
08/23
06:48
08/23/19
06:48
Recommendations
Amgen, Alexion analyst commentary  »

Amgen deal for Alexion…

AMGN

Amgen

$203.43

-0.41 (-0.20%)

ALXN

Alexion

$123.51

8.64 (7.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 02

    Oct

  • 19

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

06:47
08/23/19
08/23
06:47
08/23/19
06:47
Earnings
Foot Locker reports Q2 EPS ex-items 66c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

VWAGY

Volkswagen

$0.00

(0.00%)

06:47
08/23/19
08/23
06:47
08/23/19
06:47
Periodicals
Volkswagen looks for investment in China auto suppliers, Bloomberg says »

Volkswagen is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.